BUSINESS OPPORTUNITIES & ANALYSIS
Explore detailed reports and listings for promising product ideas and novel business strategies
Client companies of ProPharma Partners International, Inc. include multinational pharmaceutical, publicly funded biotechnology companies and late and early stage private companies. ProPharma reaches and interfaces with client companies in the United States, Europe, Japan and Australia.
South Korea Pharma inlicensing strategy provides financing opportunites to development stage companies with novel late stage products and devices: Click to view
Cyclic Mastalgia: A Large, Misunderstood Medical Condition Which Provides a Clear Opportunity for Novel Drug Development: Click to view
This Cyclic Mastalgia report evolved from a recent ProPharma Project. The Report provides an assessment of the Cyclic Mastalgia, defines the condition, addresses current therapeutic approaches, and estimates the market potential. In addition a video is attached from Robert Mansel, MD, a leading expert in the diagnosis and treatment of Cyclic Mastalgia in which he discusses the condition and the unmet needs. Following are highlights from the report:
|+1 510 681 4445||
Content © ProPharma Partners International, Inc.
Technology and Design © • All Rights Reserved